Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters.
Thrombolex has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Thrombolex is headquartered in New Britain, United States.
Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters.
Thrombolex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thrombolex — Funding & Investors." VCBacked, May 28, 2024, https://www.vcbacked.co/company/thrombolex. Accessed August 7, 2026.
VCBacked. (2024). Thrombolex — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/thrombolex
{{cite web |title=Thrombolex — Funding & Investors |url=https://www.vcbacked.co/company/thrombolex |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated